LENSAR Q1 Earnings Call Highlights

LENSAR, Inc. (LNSR) Q1 2026 Earnings Call Transcript

LENSAR® Reports First Quarter 2026 Results and Provides Business Update

LENSAR® to Report First Quarter 2026 Results on May 8, 2026

Head-To-Head Review: LENSAR (NASDAQ:LNSR) vs. Edwards Lifesciences (NYSE:EW)

LENSAR, Inc. (LNSR) Q4 2025 Earnings Call Transcript

LENSAR® Reports Fourth Quarter and Full Year 2025 Results and Provides Business Update

Contrasting DexCom (NASDAQ:DXCM) and LENSAR (NASDAQ:LNSR)

LENSAR Stock Plunges—Alcon Scraps Merger After Prolonged Regulatory Review

BYND And LNSR Set The Tone Tuesday

LENSAR® Announces Termination of Merger Agreement with Alcon Research, LLC

LENSAR® Provides Update on Pending Acquisition by Alcon

Credit Industriel ET Commercial Sells 45,117 Shares of LENSAR, Inc. $LNSR

Head to Head Analysis: LENSAR (NASDAQ:LNSR) versus enVVeno Medical (NASDAQ:NVNO)

Comparing CardioGenics (OTCMKTS:CGNH) & LENSAR (NASDAQ:LNSR)

LENSAR, Inc. $LNSR Position Increased by Groupe la Francaise

LENSAR® Reports Third Quarter 2025 Results and Provides Business Update

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LENSAR Reports Second Quarter 2025 Results and Provides Business Update

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LENSAR Reports First Quarter 2025 Results and Provides Business Update

LENSAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of LENSAR, Inc. - LNSR

ALC Stock Rises Following the Merger Agreement With LENSAR

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of LENSAR, Inc. - LNSR

Shareholder Alert: The Ademi Firm Investigates Whether LENSAR, Inc. is Obtaining a Fair Price for Its Public Shareholders

LNSR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of LENSAR, Inc. Is Fair to Shareholders

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LENSAR, Inc. (LNSR) Q4 2024 Earnings Call Transcript

LENSAR Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update

LENSAR to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 27, 2025

Medical Devices Firm Lensar Surges Ahead On Robotic Technology

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day

LENSAR, Inc. (LNSR) Q3 2024 Earnings Call Transcript

LENSAR Reports Third Quarter 2024 Results and Provides Business Update

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LENSAR to Report Third Quarter 2024 Financial Results on Thursday, November 7, 2024

One Millionth Procedure Completed Using LENSAR's Cataract Laser Systems

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LENSAR, Inc. (LNSR) Q2 2024 Earnings Call Transcript

3 Under-$10 Stocks With the Potential to Make You a Millionaire

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

LENSAR, Inc. (LNSR) Q1 2024 Earnings Call Transcript

LENSAR to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024

LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)